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Innate immune activation and chronic neuroinflammation are characteristic features of
many neurodegenerative diseases including Parkinson’s disease (PD) andmay contribute
to the pathophysiology of the disease. The discovery of misfolded alpha-synuclein (αSYN)
protein aggregates, which amplify in a “prion-like” fashion, has led us to consider that
pathogenic αSYN might be hijacking the activation and mobilization mechanism of the
peripheral immune system to reach and disseminate within the CNS. Furthermore, our lab
and other groups have recently shown that αSYN can adopt distinct fibril conformations
or “strains” with varying levels of pathogenic impact. Therefore, the aim of this study was
to assess the impact of peripheral inflammation on αSYN spreading in order to better
understand the participation of the immune system in the progression of PD. The results
presented here show that intraperitoneal LPS injection prior to systemic intravenous
recombinant administration of two different αSYN pathogenic strains (fibrils or ribbons)
in wild type mice, induces an increase in brain resident microglia and promotes the
recruitment of leukocytes toward the brain and the spinal cord. Our findings show for
the first time that αSYN can be internalized by LPS-primed inflammatory monocytes,
which in turn favors the dissemination from the periphery toward the brain and spinal
cord. Further, we found a differential recruitment of CD4+ and CD8+ T cells after LPS
priming and subsequent administration of the αSYN ribbons strain. Together, these data
argue for a role of the peripheral immune system in αSYN pathology.
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INTRODUCTION
Immunological surveillance of the central nervous system (CNS) has shown to be dynamic,
specific, and tightly regulated. Innate immune activation and chronic neuroinflammation are
characteristic features of many neurodegenerative diseases including Parkinson’s disease (PD) and
may contribute to the pathophysiology of the disease (1). During neurodegeneration, peripheral
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immune cells can gain access to the brain parenchyma (2).
Brain-resident microglia encounter myeloid immune cells that
have been previously primed in the periphery, establishing
an interplay that aggravates the inflammatory process and
potentiates neuropathology (3, 4). The recent discovery of a CNS
dural lymphatic system that drains macromolecules from the
CNS into cervical lymph nodes, further challenges the established
basic assumptions of the CNS as an immune privileged site (5–
7). Systemic injection of the endotoxin LPS has been widely
used as an inflammatory model (8, 9). These peripherally applied
stimuli lead to a cytokine-storm that signals to the brain,
triggering an immune response. The discovery of misfolded
αSYN protein aggregates with different structural characteristics,
that could account for the distinct pathological traits within
synucleinopathies and which amplify in a “prion-like” fashion
(10–14), has led us to consider that pathogenic αSYN might
be hijacking the activation and mobilization mechanism of the
peripheral immune system to reach and disseminate within
the CNS. Therefore, we assessed the impact of peripheral
inflammation on αSYN spreading in order to understand the
participation of the immune system in αSYN pathology.
MATERIALS AND METHODS
Animals and LPS/αSYN Administration
All animal experiments were carried out in accordance with the
European Communities Council Directive of 24 November 1986
(86/609/EEC) and approved by the Bioethical Committee of the
KU Leuven (Belgium). Eight-week old female C57BL/6 mice
(Janvier, France) were housed under a normal 12 h light/dark
cycle with free access to pelleted food and tap water. All surgical
procedures were performed using aseptic techniques.
Mice were treated with either (a) 20 µg of LPS i.p., (b) 5 µg
of atto-488-labeled pathogenic αSYN fibrils or ribbons i.v. (15),
(c) LPS combined with αSYN as aforementioned, or (d) saline,
following the administration scheme depicted in Figure 2A.
Twelve hours after the last injection, mice were euthanised and
immune cells were isolated from either whole brain or spinal
cord and stained for subsequent flow cytometric analysis. Results
are representative of two independent experiments combined
(n= 3–4 animals per group).
LPS from Escherichia coli 055:B5 (purified by gel filtration
chromatography) was purchased from Sigma-Aldrich and
freshly dissolved in sterile saline prior to i.p. injection.
Recombinant αSYN fibrils and ribbons were generated,
extensively characterized and labeled with the aminoreactive
fluorescent dye atto-488 (ATTO-Tech GmbH) as previously
described (13, 15).
Isolation of Immune Cells From Mice
Brains and Spinal Cords
Twelve hours after the last injection, mice were weighed
and deeply anesthetized with a ketamine (60 mg/kg,
Pfizer)/medetomidine (0.4 mg/kg, Pfizer) cocktail according
to their weight. Immune brain cells were isolated from whole
brain or spinal cord homogenates as follows. Briefly, mice were
transcardially perfused with ice-cold PBS (Gibco) and brains or
spinal cords were collected in DMEM (Gibco) supplemented
with sodium pyruvate (Gibco) and a penicillin, streptomycin and
glutamine cocktail (Gibco), gently disaggregated mechanically
and resuspended in PBS containing 3 mg/mL collagenase D
(Roche Diagnostics) plus 10µg/mL DNAse (Sigma-Aldrich)
for an enzymatic homogenization. After this incubation, brain
homogenates were filtered in 40µm pore size cell strainers
(BD Biosciences), centrifuged 8min at 1,800 r.p.m., washed
with PBS and resuspended in 6mL of 38% isotonic Percoll R©
(GE Healthcare) before a 25min centrifugation at 800G with
0 acceleration and 0 brake. Myelin and debris were discarded.
Cell pellets containing total brain immune cells were collected,
washed with DMEM supplemented with 10% fetal bovine
serum (Gibco) and cell viability was determined by trypan blue
exclusion using a Neubauer’s chamber. Finally, cells were labeled
for subsequent flow cytometric analysis.
Flow Cytometric Analysis
Surface staining of single-cell suspension of isolated brain
immune cells was performed using standard protocols and
analyzed on a FACSCanto II (BD Biosciences). Flow cytometric
analysis was defined based on the expression of CD11b, CD45,
Ly6C, CD4, and CD8 as follows: microglial cells, CD11b+
CD45lo; recruited leukocytes, CD11b+/− CD45hi; inflammatory
monocytes, CD11b+ CD45hi Ly6Chi; T cells, CD11b− CD45hi
CD4+/CD8+. Data analysis was conducted using FCS Express
(De Novo Software). The following antibodies were used in the
procedure: monoclonal anti-mouse CD11b APC (BioLegend,
clone M1/70), CD11b FITC (BD Pharmingen, clone M1/70),
CD45 APC-Cy7 (BioLegend, clone 30-F11), Ly6C PE-Cy7 (BD
Pharmingen, clone AL-21), CD4 APC (BD Pharmingen, clone
RM4-5), CD8 PE (BD Pharmingen, clone 53-6.7) or isotype
control antibodies (BDPharmingen, APC, clone R35-95; PE-Cy7,
clone G155-178). Multiparametric gating analysis strategy was
performed as previously described (8).
Statistical Analysis
Results are expressed as mean ± s.e.m. All statistical analyses
were performed using Prism R© 7.0 (GraphPad Software).
Means between groups were compared with one-way analysis
of variance followed by a Tukey’s post-hoc test. Statistical
significance levels were set as follows: ∗/# if p < 0.05, ∗∗/## if
p < 0.01, and ∗∗∗/### if p < 0.001. The asterisks indicate the
comparison against the saline treated group.
RESULTS AND DISCUSSION
The results presented here show that intraperitoneal LPS
injection combined with intravenous administration of two
different recombinant αSYN pathogenic strains (fibrils or
ribbons) in wild type mice, induces an increase in brain resident
microglia and promotes the recruitment of leukocytes toward
the brain (Figure 1A) and the spinal cord (Figure 1C). When
further characterizing the phenotypic traits of the peripheral
cells trafficking to the CNS, we identified neutrophils and
professional antigen presenting dendritic cells among innate
myeloid leukocytes (data not shown), as well as a distinct
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FIGURE 1 | αSYN hijacks the activation and mobilization mechanism of LPS-primed peripheral inflammatory monocytes to disseminate into the CNS. Mice were
treated with either (a) 20 µg of LPS i.p (LPS group), (b) 5 µg of atto-488-labeled pathogenic αSYN fibrils or ribbons i.v. (αSYN group), (c) LPS combined with αSYN
strains (LPS + αSYN group), or (d) saline alone, following the administration scheme depicted in Figure 2A. Twelve hours after the last injection, mice were euthanised
and immune cells were isolated from either whole brain (A,B) or spinal cord (C,D) and stained for subsequent flow cytometric analysis. Absolute numbers of CD11b+
CD45lo microglial cells, CD11b+/− CD45hi recruited cells, CD11b+ CD45hi Ly6Chi inflammatory monocytes, CD11b− CD45hi CD4+ and CD11b− CD45hi CD8+
lymphocytes were assessed by flow cytometry. Absolute numbers of αSYN-internalized CD11b+ CD45lo microglial cells or CD11b+ CD45hi Ly6Chi inflammatory
monocytes purified from brain (E) or spinal cord (F), were assessed by flow cytometry. Results are representative of two independent experiments combined (n = 3–4
animals per group). Representative CD11b vs. αSYN and Ly6C vs. αSYN density-plots illustrate the gating analysis strategy employed for microglial cells and
inflammatory monocytes, when gated in CD45lo or CD45hi cells respectively. Data are expressed as mean ± s.e.m. Means between groups were compared with
one-way analysis of variance followed by a Tukey’s post-hoc test. Statistical significance levels were set as follows: */# if p < 0.05, **/## if p < 0.01, and ***/###
if p < 0.001. The asterisks indicate the comparison against the saline treated group.
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FIGURE 2 | LPS/αSYN administration scheme. (A) Mice were treated i.p. with 20 µg of LPS, i.v. with 5 µg of either two atto-488-labeled pathogenic αSYN strains
(fibrils or ribbons), with LPS combined with αSYN as aforementioned, or with saline accordingly and following the administration scheme depicted. Twelve hours after
the last injection, mice were euthanised and immune cells were isolated from either whole brain or spinal cord and stained for subsequent flow cytometric analysis. (B)
Proposed model: Inflammatory monocytes, from pivotal sentinels to potential Trojan horses driving the dissemination and propagation of αSYN toward the CNS.
migration of CD4+ and CD8+ T cell subsets after administration
of αSYN strains, which was most prominent in the brain for
ribbons compared to fibrils (Figures 1B,D). Moreover, LPS-
primed inflammatory monocytes proved to be the major source
of CNS-associated phagocytes after systemic challenge with
αSYN strains. In the brain, fibrils induced a stronger response
compared to ribbons, while the effect in the spinal cord was
similar for both αSYN strains (Figures 1A,C). Interestingly,
we noticed that LPS priming favored αSYN spreading toward
the brain and spinal cord, as observed by an upregulation
of αSYN+-expressing microglia and inflammatory monocytes
(Figures 1E,F).
Mounting evidence supports the notion that the innate
immunity has a great capacity of adapting and deploying an
innate immune memory upon an inflammatory insult (16, 17),
shaping subsequent immune responses in the brain (18). Our
findings clearly demonstrate that priming with LPS prior to
systemic αSYN challenge, induces an increase in the absolute
number of the brain-resident microglia and promotes the
recruitment of peripheral leukocytes into the CNS. Similar to
other reports (19–21), our results demonstrate that stimulation
with LPS of innate immune receptors, such as Toll-like receptor
4, amplifies the inflammation within the CNS.
Sacino and colleagues were the first to describe αSYN
pathology in the brain and spinal cord induced by a single
peripheral intramuscular injection of αSYN (22). Shortly after
that, our group described passage of the blood-brain barrier
by recombinant αSYN aggregates and distribution throughout
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the CNS after systemic administration (13). Our findings
show for the first time that αSYN can be internalized by
LPS-primed inflammatory monocytes, which in turn favors
the dissemination from the periphery toward the brain and
spinal cord. In line with our results, Harms et al. (23)
described a recruitment of immune cells toward the CNS
prior to neurodegeneration after intracranial αSYN fibril
treatment. Additionally, peripheral monocyte entry was recently
reported to be required for viral vector-mediated αSYN-induced
neuroinflammation and neurodegeneration (24). Together, these
data argue for a role of the peripheral immune system in αSYN
pathology.
Further, we also found a differential recruitment of CD4+ and
CD8+ T cells after LPS priming and subsequent administration
of αSYN ribbons compared to fibrils, which was most prominent
in the brain. By presenting a different T cell response toward
distinct αSYN strains we show the importance of the protein
conformation in the capacity to act as an antigenic epitope.
Related to this, Sulzer and co-workers recently discovered that
PD patient-derived T cells are able to recognize well-defined
αSYN peptides (25). The lymphocyte activation gene-3 (LAG3)
has been proposed to bind pathogenic αSYN assemblies and to
favor their endocytosis and transmission (26). Since effector and
regulatory T cells also express LAG3, it will be important to better
comprehend the role of this membrane protein since it executes
dual roles in autoimmunity and cancer. In this regard, while
LAG3 has been shown to play a protective role in autoimmunity
by dampening T helper cell responses and promoting regulatory
T cell-mediated suppression, it has also been described to bear
co-inhibitory features, becoming a target for immune blockade
to empower anti-tumor T cell responses (27).
Having identified inflammatory monocytes as potential
disease-modifiers, we believe it is necessary to understand the
mechanism underlying the internalization and transmission
of αSYN as well as its interplay with T cells. Based on
our previous report demonstrating that type I interferons are
required to induce the selective migration of inflammatory
monocytes upon peripheral inflammation (8), targeting these
cytokines might hinder the recruitment of these cells and
therefore ameliorate the outcome of synucleinopathies like PD.
Overall, our findings demonstrate that systemic inflammation
induces the recruitment of peripheral leukocytes into the CNS,
suggesting that inflammatory monocytes could be turning
from pivotal sentinels into potential Trojan horses driving the
spreading and propagation of αSYN during disease progression
(Figure 2B).
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